Crescent Capital III is a venture capital fund part funded by the European Regional Development Fund under the EU Investment for Growth and Jobs Programme 2014-2020 – Crescent Capital III FIND OUT MORE
TissueMark software automatically marks and detects potentially cancerous sections in tissue samples with unprecedented levels of speed and accuracy... Find Out More
Belfast-based camera firm Andor Technology buys second company in two weeks Andor Technology follows £6.8m Toronto deal with California coup... Find Out More